Creating value‚ driving growth 3 7 th A N N U A L R E P O R T 2 0 0 9 - 2 0 1 0 37th ANNUAL REPORT 2009-10 Torrent Pharmaceuticals Limited 2 N TE CO N TS Corporate Information 02 Notice 03 Directors’ Report 06 Report on Corporate Governance 14 Auditors’ Report 24 Audited Financial Statements 28 Management Discussion and Analysis 55 Consolidated Financial Statements 66 37th ANNUAL REPORT 2009-10 3 CORPORATE INFORMATION DIRECTORS Sudhir Mehta Chairman REGISTERED
Premium Board of directors Corporate governance
constantly replenish the supply of potential blockbusters requires a consistent and dedicated approach to drug R&D. However no longer is inhouse research expertise sufficient. 2 Chart 1 Decreased R&D Productivity (source: FDA - PhRMA 2007) Pharma R&D Investments (Billion USD) 120 New medicines Approved by FDA 60 100 50 80 40 60 30 40 20 20 10 0 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 YEAR 0 To fill this pipeline gap‚ pharmaceutical
Premium Net present value Discounted cash flow Cash flow
Company Background Square Pharmaceuticals Limited has been a household name in Bangladesh since 1958 when it started its operations as a partnership‚ getting incorporated in 1964 and finally getting listed at the stock exchange in 1995. The company has been in the leading front of innovation‚ and continues to introduce new and better medicines in the market every year. Today the 97% of the demands for medicine in the domestic market is catered to by the local pharmaceuticals company and Square
Premium Financial ratios Financial ratio Revenue
This valuation takes place with the proper implementation of HRM. There are many aspects of HRM and our concerned one is „Performance Appraisal”. We have studied and observed the “Performance Appraisal” process of BEXIMCO TEXTILES LTD. one of the well-known & biggest textiles of Bangladesh. We tried to know how they made “Performance Appraisal” for their Executives. To compete effectively the organization must understand: 1 What is needed for making “Performance Appraisal” 2. Who are the major Rectors
Premium Human resource management
1) Millenniums Pharmaceuticals strategy basically focused on revolutionizing drug development through the use of new technology during growth phase and making organizational changes during its maturing phase of by making strategic improvements in the organizational structure‚ making alliances‚ outsourcing etc by having vertical integration and moving from upstream to downstream model. In phase 1‚ technology helped the firm leapfrog most other biotechnology firms in the early stage of drug target
Premium Strategic management
Bio Pharma Case Analysis Question 1 How should BioPharma have used its production network in 2009? Should any of the plants have been idled? What is the annual cost of your proposal‚ including import duties? As Landgraf’s objective is to design a more cost-effective network (cost minimization problem subject to various capacity constraints)‚ the following production network in 2009 should have been used by BioPharma: *All numbers below are in millions *Total Transportation Cost=SUMPRODUCT
Premium Costs Total cost Variable cost
The flagship company of the Square group of industries‚ Square Pharmaceuticals Limited (SPL) is the largest pharmaceuticals company in Bangladesh. Founded in 1958 and headquartered in Dhaka‚ Bangladesh‚ SPL develops‚ manufactures and markets drugs for humans and the animal world. The company owns and operates modern pharmaceutical factories mainly in Bangladesh and also has a separate division to operate a modern chemical factory which produces and sells basic chemical products. It also has divisions
Premium Pharmaceutical industry Pharmacology
Cost Accounting: In a broad aspects‚ Cost Accounting is a method of accounting in which all costs incurred in carrying out an activity or accomplishing a purpose are collected‚ classified‚ and recorded. This data is then summarized and analyzed to arrive at a selling price‚ or to determine where savings are possible. So Cost Accounting consists of the identification‚ measurement‚ collection‚ analysis‚ preparation‚ and communication of financial information For example‚ calculating the cost of product
Premium Costs Cost Cost accounting
didn’t disclose it to us. In this report the terms and conditions that we have learned in FIN 406 has implemented. In this report financial analysis and recommendations are given. Introduction part Company overview The Beximco Textiles Ltd. was incorporated in Bangladesh as a Public Ltd. Company with limited liability on 1994 & commenced commercial operation in 1995. The project was set up as a state of the art fabric weaving‚ dyeing & finishing facilities for production of high quality
Premium Balance sheet Inventory Working capital
Birmingham‚ November 2011 Nico Bacharidis Globally‚ Tenders & Contracts cover more than half of the Gx market‚ and also affect around 14% of the patented pharma market . In Mature markets the share of tenders - both patented and protected – is a bit lower. •Estimated Size1) of Tendered and Contracted Pharma Market ($bn) •27% of total pharma •$210bn 767 160 Tendered Contracted 141 Generics Total Gx Mar ket •Tendered and Contracted Market by Gx and Patented ($bn) 210 •Over 50% of the global
Premium European Union United Kingdom Western Europe